Indonesia seeks to launch home-grown Covid-19 vaccine in third quarter


A healthcare worker inoculates a woman with a dose of the Pfizer vaccine against the Covid-19 during a mass vaccination at a shopping mall in Jakarta. Indonesia has aimed to develop and manufacture its own vaccines domestically since the start of the pandemic. - Reuters

JAKARTA, Feb 20 (Jakarta Post/ANN): Indonesia will seek to launch a home-grown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now under way.

Analysts said it was an important development for Indonesia, where more than 65 per cent of the eligible population have been fully vaccinated against Covid-19, if a vaccine can be produced domestically from a trusted source.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Indonesia , Covid-19 , Home Grown , Vaccine , Third Quarter , 2022

Next In Aseanplus News

South Korean researchers find way to remove nanoplastics from water in 10 minutes
Committee formed to review salaries of Singapore's political appointment holders: Chan Chun Sing
Kelantan Police Chief targeted after reopening over 100 ‘along’ cases
Ringgit extends gains against US$ at opening
FBM KLCI hits 1,700 as banks surge to record levels
SK Hynix to invest nearly $13 billion in chip packaging plant in South Korea
HK actress Selena Lee reconciles with ex-fiance, 10 months after split
‘Bersatu did not sabotage PAS in Perlis’, Muhyiddin denies traitor accusations
S&P 500, Dow hit closing record highs; Walmart, tech climb
Bursa Malaysia benchmark hits new six-year high

Others Also Read